ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M-positive non-small cell lung cancer (NSCLC) European subset

Autor:	David Vicente, J. Rigas, M. Tiseo, Johan Vansteenkiste, F. De Marinis, Maximilian Hochmair, M. Miranda, Giulio Metro, T. Geldart, K. Lamberg, Teresa Moran, A. Paredes, C. Nyhus, Antonio Santo, E. Hanrahan
Jazyk:	angličtina
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) EGFR T790M Hematology medicine.disease Treatment study Internal medicine Medicine Osimertinib In patient business
Zdroj:	Tiseo, M, Santo, A, Hochmair, M J, Geldart, T, Metro, G, Hanrahan, E, Lamberg, K, Moran, T, Nyhus, C, Paredes, A, Vansteenkiste, J F, Vicente, D, Miranda, M, Rigas, J & de Marinis, F 2018, ' ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M-positive non-small cell lung cancer (NSCLC) European subset ', Annals of Oncology, vol. 29, no. Suppl. 8, pp. viii528 . https://doi.org/10.1093/annonc/mdy292.083
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f556ec92a8538d91ab8dc58b9867a9 https://portal.findresearcher.sdu.dk/da/publications/885d4b5b-ed23-4c05-9c3f-a3515e4a13c7 Zobrazit plný text záznamu